Response to ASX price query
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Later from PYC Therapeutics
- Combination therapy escalates potency of Phylogica peptides
- Entitlement Issue and Note Conversion
- New Patent to Discover Sophisticated Cell Penetrating Drugs
- Core patent granted in Australia
- European Patent Granted
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics